PELOSI, NANCY BUYNVDA$500K–$1M·TUBERVILLE, TOMMY BUYMSFT$50K–$100K·CRENSHAW, DAN SELLXOM$15K–$50K·PELOSI, NANCY BUYNVDA$500K–$1M·TUBERVILLE, TOMMY BUYMSFT$50K–$100K·CRENSHAW, DAN SELLXOM$15K–$50K·
← Leaderboard
GMAB
Ticker

GMAB

Congressional Trades
4
by 1 members
Buys
2
50%
Sells
2
50%
Total Volume
$32K
midpoint
Unique Traders
1
members

Party Breakdown

Democrats4 · 100%
Republicans0 · 0%

Party Trading Divergence

Democrat vs. Republican buy / sell pressure by monthALIGNED

Bar length = total trades. Color = net sentiment — green = net buying, red = net selling. Months with no activity hidden.

Democrat ←
Month
→ Republican
01
Jun '24
1
Jul '24
01
Dec '24
1
Jan '25
Democrats22Neutral
vs
Republicans00Neutral
Net buyingNet selling⚡ Party split

💼 Lobbying Filings

all →
  • 2026-04-20$60K
    GENMAB
    Prescription Drug Pricing. Implementation of Inflation Reduction Act of 2022. General Medicare/Medicaid Issues. 340B Issues.
  • 2026-04-15$60K
    GENMAB US INC.
  • 2026-01-20$60K
    GENMAB
    General Medicare/Medicaid Issues. 340B Issues. Prescription Drug Pricing. Implementation of Inflation Reduction Act of 2022.
  • 2026-01-14$60K
    GENMAB US INC.
  • 2025-10-15$60K
    GENMAB US INC.
    Guidance on legislation and regulations regarding the creation and development of differentiated antibody therapeutics.
  • 2025-10-12$60K
    GENMAB
    Prescription Drug Pricing. Implementation of Inflation Reduction Act of 2022. General Medicare/Medicaid Issues. 340B Issues.
  • 2025-07-19$60K
    GENMAB
    Prescription Drug Pricing. Implementation of Inflation Reduction Act of 2022. General Medicare/Medicaid Issues. 340B Issues.
  • 2025-07-15$60K
    GENMAB US INC.
    Guidance on legislation and regulations regarding the creation and development of differentiated antibody therapeutics.
  • 2025-04-21$60K
    GENMAB
    Prescription Drug Pricing. Implementation of Inflation Reduction Act of 2022. General Medicare/Medicaid Issues. Safe STEP Act. 340B Issues.
  • 2025-04-15$60K
    GENMAB US INC.
    Guidance on legislation and regulations regarding the creation and development of differentiated antibody therapeutics.

Congressional Momentum

buy vs. sell pressureNEUTRAL

Score 0–100: above 50 = net buying pressure, below 50 = net selling. Signal based on last 90 days.

Last 30 Days
No trades
Last 90 Days
No trades
All-Time
50
2 buys4 total2 sells
$16K buys · $16K sells
Cumulative Net Position (buy vol − sell vol)
+$0
2024-064 trades plotted2025-01

Trade Activity Timeline

Congressional buys & sells by month · last 4 months w/ activity

24/06
24/07
24/12
25/01
BuysSellsOtherHigh-volume month

All Disclosed Trades

DateMemberActionAmountFiling Delay
2025-01-16DJosh GottheimerBUY$1K – $15K25d
2024-12-16DJosh GottheimerSELL$1K – $15K29d
2024-07-19DJosh GottheimerBUY$1K – $15K27d
2024-06-18DJosh GottheimerSELL$1K – $15K21d